PLX vs UBER · P/E 31, rev $53.4M vs P/E 18, rev $52.02B
Protalix Biotherapeutics Inc (PLX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
PLX currently screens at market cap $122.6M and trailing P/E 30.8. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the PLX and UBER stock pages for the full models.
Not investment advice.